MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Fortress Biotech Inc

Ouvert

2.76 -4.17

Résumé

Variation du prix de l'action

24h

Actuel

Min

2.68

Max

2.84

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+417.86% upside

Dividendes

By Dow Jones

Prochains Résultats

12 nov. 2025

Fortress Biotech Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 oct. 2025, 15:07 UTC

Principaux Mouvements du Marché

Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility

10 mars 2025, 02:12 UTC

Acquisitions, Fusions, Rachats

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 mars 2025, 02:12 UTC

Acquisitions, Fusions, Rachats

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 mars 2025, 02:11 UTC

Acquisitions, Fusions, Rachats

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 mars 2025, 02:11 UTC

Acquisitions, Fusions, Rachats

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 mars 2025, 02:10 UTC

Acquisitions, Fusions, Rachats

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 mars 2025, 02:10 UTC

Acquisitions, Fusions, Rachats

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 mars 2025, 02:06 UTC

Acquisitions, Fusions, Rachats

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT

Comparaison

Variation de prix

Fortress Biotech Inc prévision

Objectif de Prix

By TipRanks

417.86% hausse

Prévisions sur 12 Mois

Moyen 14.5 USD  417.86%

Haut 17 USD

Bas 12 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Éléments financiers

$

help-icon Live chat